Literature DB >> 12490098

Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis.

Jianshe Wang1, Qirong Zhu, Xiuzhen Zhang.   

Abstract

OBJECTIVE: To study the effect of different delivery modes on immunoprophylaxis efficacy so as to clarify whether or not cesarean section reduces immunoprophylaxis failure.
METHODS: Mothers with positive hepatitis B surface antigen (HBsAg) were selected in the third trimester of pregnancy. Their babies were inoculated with hepatitis B immunoglobulin at birth and hepatitis B vaccine at 1, 2 and 7 months of age. HBsAg and its antibodies (anti-HBs) were tested at 1, 4, 7, and 12 months of age, then followed up yearly.
RESULTS: A total of 301 babies entered the study, including 144 born by normal spontaneous vaginal delivery, 40 by obstetric forceps or vacuum extraction, and 117 by cesarean section. The incidence of mother's HBeAg positivity or baby's gender constitution was comparable between the three groups. There were no significant differences in the positive rate of anti-HBs or HBsAg at follow-up periods among the three groups. At 12 months of age, anti-HBs could be detected in 78.9% of the babies born by normal vaginal delivery, 84.6% of the babies by forceps or vacuum extraction, and 86.4% of the babies by cesarean section. The positive rate of HBsAg was 8.1%, 7.7%, 9.7%, and chronic HBV infection incidence was 7.3%, 7.7%, 6.8% respectively.
CONCLUSIONS: There are no significant effects of delivery mode on the interruption of HBV maternal-baby transmission by immunoprophylaxis. Cesarean section does not reduce the incidence of immunoprophylaxis failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490098

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  25 in total

1.  A disappearing vertical infection: will hepatitis B be a forgotten disease in children?

Authors:  Byung-Ho Choe
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

Review 2.  Chronic hepatitis B virus infection and pregnancy.

Authors:  Manoj Kumar; Tarandeep Singh; Swati Sinha
Journal:  J Clin Exp Hepatol       Date:  2012-09-20

Review 3.  Hepatitis B and C.

Authors:  Wikrom Karnsakul; Kathleen B Schwarz
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

Review 4.  Hepatitis B and C in pregnancy: a review and recommendations for care.

Authors:  J C Dunkelberg; E M F Berkley; K W Thiel; K K Leslie
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

Review 5.  Individualized management of pregnant women with high hepatitis B virus DNA levels.

Authors:  Zhao Zhang; Chao Chen; Zhe Li; Ying-Hua Wu; Xiao-Min Xiao
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Liver diseases in pregnancy: diseases not unique to pregnancy.

Authors:  Ashraf A Almashhrawi; Khulood T Ahmed; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 8.  Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis.

Authors:  Hua Xu; Teng Zeng; Jun-Ying Liu; Yu Lei; Shan Zhong; Yun-Jian Sheng; Zhi Zhou; Hong Ren
Journal:  Dig Dis Sci       Date:  2013-11-06       Impact factor: 3.199

9.  Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene.

Authors:  Wen-Jun Gao; Xiao-Mou Peng; Dong-Ying Xie; Qi-Feng Xie; Zhi-Liang Gao; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

10.  Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women.

Authors:  Z Guo; X H Shi; Y L Feng; B Wang; L P Feng; S P Wang; Y W Zhang
Journal:  J Viral Hepat       Date:  2012-12-05       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.